Item 61
approvedFeb 21, 2024
Description
Authorize additional funding in the amount of $4,006,000 for prescription drug expenses to cover projected shortfalls for the remainder of Fiscal Year 2024. Effective upon G&C approval through June 30, 2024. 100% General Funds. Contingent upon Fiscal Committee approval on February 16, 2024.
Vote Record
approved
Motion by Warmington, seconded by Kenney authorized additional funding in the amount of
Joseph Kenney
(R)
yes
Cinde Warmington
(D)
yes
Janet Stevens
(R)
yes
Ted Gatsas
(R)
yes
Dave Wheeler
(R)
yes
Documents (1)
Item_61.pdf
Open in new tab →